Figure 5From: Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis Antihypertensive drug costs before and after index date for various patient populations. ARB: angiotensin-receptor blocker, CCB: calcium-channel blocker. Changes in antihypertensive drug costs were statistically significant at 1% (**) levels according to t-tests.Back to article page